Retrieve Medical Holdings, Inc.
OperatingBiotech · Bedminster, NJ
Financials
FY2009–FY2022 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 6 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Dec 16, 2022| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common stock | 78,363,567 | — | 100.0% | $1.00Mar 2024 |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Talal Yassin24K (6.22%) Jan 2015 → 15 Sep 2017
- Arnold Tinter164 (0.1%) Dec 2013 → 1K (0.26%) Jan 2015 → 1K (0.32%) Jan 2016
Principal holders% as the filing states it, Mar 14, 2024
- Jerry Swon3,026,923 Common Stock14.9%of votes
Sold to the crowd
- Reg CF · Mar 202457,581 shares at $1.00$57.6K· 24 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
1 personNames and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 0 of 3 annual reports (FY2023–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 66 filings on EDGAR- Form DOct 28, 20240001199835-24-000466EDGAR
- Form C-USep 17, 20240001213900-24-079467EDGAR
- Form C/AMay 10, 20240001213900-24-041799EDGAR
- Form CMar 14, 20240001213900-24-022543EDGAR
- Form DAug 14, 20230001199835-23-000444EDGAR
- Form 10-QFeb 9, 20230001199835-23-000089EDGAR
- Form 10-QDec 19, 20220001199835-22-000832EDGAR
- Form 10-KDec 19, 20220001199835-22-000830EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.